[Translation] A single-dose, randomized, open-label, four-period, completely repeated crossover bioequivalence study of doxofylline tablets in healthy subjects under fasting conditions
主要研究目的:
研究空腹状态下单次口服受试制剂多索茶碱片(规格:400mg,江苏宣泰药业有限公司)与参比制剂多索茶碱片(商品名:ANSIMAR®,规格:400mg,ABC FARMACEUTICI S.P.A.)在健康成年受试者体内的药代动力学,评价空腹状态下口服两种制剂的生物等效性。
次要研究目的:
评价健康受试者空腹单次口服受试制剂(T)多索茶碱片和参比制剂(R)多索茶碱片(商品名:ANSIMAR®)后的安全性。
[Translation] Main study objectives:
To study the pharmacokinetics of the test preparation Doxofylline Tablets (Specification: 400mg, Jiangsu Xuantai Pharmaceutical Co., Ltd.) and the reference preparation Doxofylline Tablets (Trade name: ANSIMAR®, Specification: 400mg, ABC FARMACEUTICI S.P.A.) in healthy adult subjects after a single oral administration under fasting conditions, and to evaluate the bioequivalence of the two preparations after oral administration under fasting conditions.
Secondary study objectives:
To evaluate the safety of the test preparation (T) Doxofylline Tablets and the reference preparation (R) Doxofylline Tablets (Trade name: ANSIMAR®) after a single oral administration under fasting conditions in healthy subjects.